REVTORPYK
Live / Applied — Statement of use — registration review complete (as of 04 Nov 2026)
What this means for you
Not registered yet, but its 12 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99650454
- Mark type
- Design + words
- Filed
- 12 Feb 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Anthony Laurentano
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer in humans
Owner
- Celcuity Inc., Minneapolis, MN, US
- Celcuity Inc., Minneapolis, MN, US
Prosecution history
- 04 Nov 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Nov 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Nov 2026 — USE AMENDMENT FILED
- 02 Nov 2026 — TEAS STATEMENT OF USE RECEIVED
- 08 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jun 2026 — ASSIGNED TO EXAMINER
- 11 Jun 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 11 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Feb 2026 — NEW APPLICATION ENTERED